article thumbnail

Antibody Drug Conjugates Keep Growing: What You Need to Know

JD Supra: Mergers

Over the past few years economic headwinds have resulted in fewer deals, with companies and private equity firms alike reassessing where to spend money. Since 2018, licensing deals totaling over US$60 billion have been signed regarding ADCs, with 2023 alone having at least 18 deals. What Are ADCs and Why Are They Growing?

article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: Linden to Sell Specialty Networks to Cardinal Health for $1.2 Billion

JD Supra: Mergers

Specialty Networks, founded in 2018 and based in Cleveland, is an integrated, multi-specialty organization with group purchasing organizations, life sciences and research solutions in urology, gastroenterology and rheumatology. Linden Capital Partners has announced it will sell Specialty Networks to Cardinal Health for $1.2 billion in cash.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

In a slow year for enterprise tech M&A, there were few standout deals

TechCrunch: M&A

It was a slow year in enterprise technology M&A, and the total was the second lowest since we started compiling the data in 2018. © 2023 TechCrunch. All rights reserved. For personal use only.

M&A 286
article thumbnail

The essential guide to raising private equity

Growth Business

By Dom Walbanke on Growth Business - Your gateway to entrepreneurial success Raising private equity funds is seen as the holy grail for businesses who want to grow quickly, simply because the strength of capital opens the door for rapid growth.

article thumbnail

Debt Default Activism: Consideration for Acquirers Looking to Maintain Target’s Low Rate Debt

Deal Lawyers

Since 2018, John has addressed the debt default activism phenomenon on this blog and discussed related considerations, including contractual provisions designed to thwart default activists.

Debt 100
article thumbnail

AI company Hypergiant Industries snapped up by PE firm Trive Capital

TechCrunch: M&A

Private equity firm Trive Capital has acquired Hypergiant Industries in a deal that will furnish the Texas-based AI company with capital to “build even faster,” Hypergiant CEO Mike Betzer told TechCrunch in a recent interview. The terms of the deal were not disclosed.

Capital 230
article thumbnail

Should You Jump on the Private Equity Bandwagon?

Sica Fletcher

In recent posts, we outlined the background of and reasons for the dramatic upsurge of private equity investment in the insurance brokerage industry , how the combination of private equity and low interest rates have dramatically raised valuations , and how private equity sponsored agencies increasingly dominate the insurance agency business.